Autoradiographic localization of 5-HT(2A) receptors in the human brain using [3H]M100907 and [11C]M100907

Synapse

Volumn 38, Issue 4, 2000, Pages 421-431

  Hall, Håkan ^a   Farde, Lars ^a   Halldin, Christer ^a   Lundkvist, Camilla ^a   Sedvall, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5 HT(2A) receptors; 11C M100907; 3H M100907; Human brain; Whole hemisphere autoradiography

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; DOPAMINE 2 RECEPTOR BLOCKING AGENT; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RACLOPRIDE; RECEPTOR SUBTYPE; SEROTONIN 1A ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR;

ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING;

ADULT; AUTORADIOGRAPHY; BRAIN; CARBON RADIOISOTOPES; FEMALE; FLUOROBENZENES; HUMANS; MALE; MIDDLE AGED; NEOCORTEX; PIPERIDINES; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; TISSUE DISTRIBUTION; TRITIUM;

EID: 0034672836     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(20001215)38:4<421::AID-SYN7>3.0.CO;2-X     Document Type: Article

References (49)

1. The role of cognition in the risk-benefit and safety analysis of antipsychotic medication
2. Serotonin, schizophrenia and antipsychotic drug action
3. 1 dopamine receptors
4. The safety, tolerability, pharmacokinetics and pharmacodynamics of a selective 5-HT2A antagonist. M100907, following single and multiple oral dosing in healthy volunteers
5. The distribution of 5-HT(1A) and 5-HT(2A) receptor mRNA in human brain
6. The selective 5-HT(2A) receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neuretransmission in the mouse-implications for psychosis
7. Serotonin-dopamine antagonists and treatment of negative symptoms
8. Decreased frontal cortical serotonin(2A) receptors in schizophrenia
9. Positron emission tomography - Examination of chemical transmission in the living human brain. Development of radioligands
10. [C-11]FLB 457, a selective PET radioligand for examination of extrastriatal dopamine D2 receptors
11. 2 receptor binding in risperidone-treated schizophrenic patients
12. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain
13. 2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study
14. 125I]epidepride
15. 11C]WAY-100635
16. Whole hemisphere autoradiography of the postmortem human brain
17. 2 receptor binding in patients with chronic schizophrenia
18. PET imaging of central 5-HT(2A) receptors with carbon-11-MDL 100,907
19. 3H]MDL 100,907: A novel selective 5-HT(2A) receptor ligand
20. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics
21. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT(2A) antagonist with a favorable CNS safety profile
22. Serotonergic component of neuroleptic receptors
23. 2 receptor binding sites - Binding properties, distribution, and functional role
24. 3H]MDL 100,907
25. 3H]MDL 100,907 labels 5-HT(2A) serotonin receptors selectively in primate brain
26. 3]ketanserin
27. [C-11]MDL 100907, a radioligand for selective imaging of 5-HT(2A) receptors with positron emission tomography
28. 3H]Ketanserin binding in human brain postmortem
29. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT(2A) receptors
30. An overview of the mechanism of action of clozapine
31. 2 affinities differentiate atypical and typical antipsychotic drugs
32. Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT(2A) antagonist
33. 2 receptor occupancy in clozapine treated patients demonstrated by PET
34. 2 receptor occupancy in relation to clozapine serum concentration. A PET study of schizophrenic patients
35. 2 dopamine receptor occupancy in the living human brain. A PET study with risperidone
36. The role of serotonin in schizophrenia: An overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system
37. 5-HT modulation of auditory and visual sensorimotor gating. II. Effects of the 5-HT(2A) antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats
38. 11C-Ro 15-1788 binding to human brain sections
39. The selective 5-HT(2A) receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat
40. The role of 5-HT(2A) receptors in antipsychotic activity
41. Monoamines and schizophrenia
42. Utilization of radioligands in schizophrenia research
43. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis
44. 2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: Behavioral, electrophysiological and neurochemical studies
45. Serotonin(1A) receptors are increased in postmortem prefrontal cortex in schizophrenia
46. High 5HT(2A) receptor occupancy in M100907-treated schizophrenic patients
47. Binding sites for 5-hydroxytryptamine-2 receptor agonists are predominantly located in striosomes in the human basal ganglia
48. Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum
49. 2 receptor subtype mRNAs in rat brain